PRTN3 and rheumatoid arthritis: During the last decade, in addition to ACPA, anti-carbamylated protein (anti-CarP) antibodies were highlighted as important biomarker for RA [65,134,135,136], which can be detected in patients’ serum years before disease onset [137,138] and increase gradually just before and during the manifestation of clinical symptoms [95,112].